Sangeeta N. Bhatia is a venture partner at Catalio Capital Management and director of MIT’s Marble Center for Cancer Nanomedicine. Her work spans nanomedicine for cancer and liver disease, and she co-founded Hepregen, Glympse Bio, Satellite Bio and Impilio Therapeutics.
Sangeeta N. Bhatia is a venture partner at Catalio Capital Management and director of MIT’s Marble Center for Cancer Nanomedicine. Her work spans nanomedicine for cancer and liver disease, and she co-founded Hepregen, Glympse Bio, Satellite Bio and Impilio Therapeutics.
Career
Sangeeta N. Bhatia studied at Brown University (BSc), Harvard Medical School (MD), and Massachusetts Institute of Technology (PhD).
Venture Partner at Catalio Capital Management until Present
Director, Marble Center for Cancer Nanomedicine at Massachusetts Institute of Technology until Present